Dr. Ruiwen Zhang

Dr. Zhang obtained MD (with highest honor) and PhD (Toxicology) from Fudan University Shanghai Medical College and completed a post-doctoral/clinical pharmacology fellowship at University of Alabama School of Medicine (UAB). He joined UAB faculty in 1992 and moved through the ranks to Tenured Professor and Cancer Pharmacology Laboratory Director. He joined TTUHSC School of Pharmacy in July 2010. Dr. Zhang’s research has been continuously funded by NIH, DoD, and other agencies, publishing > 180 papers, 2 books, > 50 invited reviews/book chapters. with >6,800 citations (H-index, 47). He is a certified toxicologist by American Board of Toxicology (D.A.B.T.) and was an ABT Board Director (2009-2013). He is an FDA advisory committee member and study section member for NIH, DoD, CDC, FDA, and NIOSH. Dr. Zhang was elected as Fellow of American Association for the Advancement of Science (AAAS) in 2009. He is Editor-in-Chief of Current Cancer Drug Targets.

External Link (www.ttuhsc.edu)